STAT3 expression in activating EGFR-driven adenocarcinoma of the lung
STAT3 expression in activating EGFR-driven adenocarcinoma of the lung
复制标题
STAT3 表达激活 EGFR 驱动的肺腺癌
DOI:
10.1016/j.lungcan.2011.05.015
复制
发表时间:
2012
期刊:
影响因子:
5.3
通讯作者:
Kiura Katsuyuki
中科院分区:
文献类型:
--
作者:
Takata Saburo;Takigawa Nagio;Segawa Yoshihiko;Kubo Toshio;Ohashi Kadoaki;Kozuki Toshiyuki;Teramoto Norihiro;Yamashita Motohiro;Toyooka Shinichi;Tanimoto Mitsune;Kiura Katsuyuki
Bronchioloalveolar carcinoma (BAC) pattern is often seen at the margin of invasive adenocarcinomas. We investigated EGFR signaling abnormalities involved in the progression of adenocarcinoma. Fifty tumors were obtained from patients who underwent surgery for lung adenocarcinoma seen as dense areas in ground glass opacity on computed tomography. Six, 18, and 26 tumors <1cm, 1–2cm, and ≥2cm in diameter, respectively, were analyzed. Of the 24 tumors ≤2cm in diameter, nine were preinvasive and 15 were invasive. EGFR, pAKT, and pMAPK were overexpressed in the center of the adenocarcinoma compared to the BAC component (p<0.01) by immunohistochemistry, while pSTAT3 expression was reversed (p=0.017). In the tumors ≤2cm in diameter, pSTAT3 expression in the central area was higher in preinvasive tumors than in invasive tumors (p=0.005). pSTAT3 was identified in the BAC component of 88% of the EGFR mutant (n=17) and 82% of the wild-type tumors (n=33). Transgenic mice expressing delE748-A752 EGFR and two lung cancer cell lines (PC-9 mutant and A549 wild-type EGFR) were also investigated. In transgenic mice, pSTAT3 was overexpressed in the BAC component around the adenocarcinoma center. Two lung cancer cell lines that overexpressed pSTAT3 were equally sensitive to a JAK2/STAT3 inhibitor (JSI-124). The role of STAT3 in the progression of adenocarcinoma should be further pursued.